CA
CRISPR Therapeutics AG
CRSP
NASDAQHealth Care
Income Statement
Total Revenue$37.31M
Gross Profit$37.31M
Operating Income$-466.57M
EBITDA$-343.41M
EBIT$-362.67M
Pre-tax Income$-565.17M
Net Income$-366.25M
Balance Sheet
Net Cash$4.23B
Cash Equivalent$440.48M
Total Debt$229.37M
Net Debt$-4B
Book Value$1.98B
Net Cash Per Share43.92
Book Value Per Share23.64
Key Ratios
Return on Equity (ROE)-18.96%
Return on Assets (ROA)-16.34%
Return on Invested Capital (ROI)-18.96%
Net Profit Margin-981.54%
Current Ratio22.07
Quick Ratio21.97
Long-Term Debt / Equity0.00